ADENOCARCINOMA OF LUNG, RESPONSE TO TYROS
|
ADENOCARCINOMA OF LUNG, SOMATIC
|
AORTIC ANEURYSM, FAMILIAL THORACIC 7
|
BREAST CANCER, SUSCEPTIBILITY TO
|
CARDIOFACIOCUTANEOUS SYNDROME 1
|
CARDIOFACIOCUTANEOUS SYNDROME 3
|
CARDIOFACIOCUTANEOUS SYNDROME 4
|
CATARACT 6, AGE-RELATED CORTICAL
|
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, WITH HIRSCHSPRUNG DISEASE
|
CEREBRAL INFARCTION, SUSCEPTIBILITY TO
|
CHRONIC MYELOID LEUKEMIA, RESISTANT TO IMATINIB
|
COFFIN-LOWRY SYNDROME
|
COFFIN-LOWRY SYNDROME, MILD
|
COLORECTAL CANCER, SOMATIC
|
COLORECTAL CANCER, SOMATIC, INCLUDED;;
|
COWDEN DISEASE 6
|
DIABETES MELLITUS, TYPE II
|
ENDOCRINE-CEREBROOSTEODYSPLASIA
|
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2
|
FG SYNDROME 4
|
GASTROINTESTINAL STROMAL TUMOR, FAMILIAL
|
GASTROINTESTINAL STROMAL TUMOR, SOMATIC
|
GLYCOGEN STORAGE DISEASE IXC
|
HARTSFIELD SYNDROME
|
HEPATOCELLULAR CARCINOMA, CHILDHOOD TYPE, SOMATIC
|
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1
|
HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA
|
HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA, SUSCEPTIBILITY TO
|
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA, SUSCEPTIBILITY
|
HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA
|
HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO
|
IN
|
LEUKEMIA, PHILADELPHIA CHROMOSOME-POSITIVE, RESISTANT TO IMATINIB
|
LYMPHOMA, NON-HODGKIN, SOMATIC
|
MALFORMATIONS
|
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME
|
MELANOMA, MALIGNANT, SOMATIC
|
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA
|
MENTAL RETARDATION, X-LINKED 19
|
MENTAL RETARDATION, X-LINKED 30
|
MENTAL RETARDATION, X-LINKED, WITH NYSTAGMUS
|
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
|
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB
|
NEUROPATHY, HEREDITARY SENSORY, TYPE II
|
NONSMALL CELL LUNG CANCER, RESISTANCE TO TYROSINE KINASE INHIBITOR
|
NONSMALL CELL LUNG CANCER, RESPONSE TO TYROSINE KINASE INHIBITOR IN,
|
NOONAN SYNDROME 7
|
OGUCHI DISEASE 2
|
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT
|
PEUTZ-JEGHERS SYNDROME
|
PHEOCHROMOCYTOMA, INCLUDED
|
PHEOCHROMOCYTOMA, SOMATIC, IN
|
PROSTATE CANCER, PROGRESSION AND METASTASIS OF
|
RENAL AGENESIS
|
RENAL CELL CARCINOMA, PAPILLARY, 1
|
RENAL CELL CARCINOMA, PAPILLARY, 1, SOMATIC
|
RETINITIS PIGMENTOSA 38
|
RETINITIS PIGMENTOSA 62
|
SHORT RIB-POLYDACTYLY SYNDROME, TYPE IIA
|
SOMATIC
|
SPERMATOGENIC FAILURE 5
|
SPINOCEREBELLAR ATAXIA 14
|
T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AUTOIMMUNITY, AND CARDIAC
|
TESTICULAR TUMOR, SOMATIC
|
THROMBOCYTOPENIA 2
|
THYROID CARCINOMA, FAMILIAL MEDULLARY
|
THYROID CARCINOMA, FAMILIAL MEDULLARY, INCLUDED
|
THYROID CARCINOMA, FOLLICULAR, SOMATIC, INCLUDED
|
THYROID CARCINOMA, PAPILLARY, SOMATIC, INCLUDED;;|
|
THYROID CARCINOMA, SPORADIC MEDULLARY, INCLUDED;;
|
TO
|
VARIANT OF UNKNOWN SIGNIFICANCE
|
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL
|